Plain-English translation of NCT07071506 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing fremanezumab, a medication designed to prevent chronic migraines, in adults who experience frequent migraine headaches. The study uses a special research method to better understand how well this medication works compared to a placebo (an inactive injection). Researchers will track your migraine patterns over eight months while you receive injections, half of which will be the active medication and half of which will be placebo.
Standard migraine prevention research may not capture the true effectiveness of treatments because patients' beliefs about what they're receiving can influence results. This study uses a new approach to separate the real effects of the medication from the psychological benefits of receiving treatment, which could lead to better ways of testing migraine prevention drugs in the future.
You likely qualify if…
You likely don't qualify if…
You would receive four injections over eight months, with one injection given every two months (starting after an initial month without treatment). The injections look identical, and neither you nor the researchers will know whether each injection contains the active medication or placebo. Throughout the study, you'll keep a daily electronic diary rating your headaches and migraine symptoms, and you'll complete questionnaires about your quality of life and how migraines affect you.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Denmark